Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Methylindoles and Methoxyindoles are Agonists and Antagonists of Human Aryl Hydrocarbon Receptor

M. Stepankova, I. Bartonkova, E. Jiskrova, R. Vrzal, S. Mani, S. Kortagere, Z. Dvorak,

. 2018 ; 93 (6) : 631-644. [pub] 20180406

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem, Research Support, U.S. Gov't, Non-P.H.S.

Perzistentní odkaz   https://www.medvik.cz/link/bmc19012735

Novel methylindoles were identified as endobiotic and xenobiotic ligands of the human aryl hydrocarbon receptor (AhR). We examined the effects of 22 methylated and methoxylated indoles on the transcriptional activity of AhRs. Employing reporter gene assays in AZ-AHR transgenic cells, we determined full agonist, partial agonist, or antagonist activities of tested compounds, having substantially variable EC50, IC50, and relative efficacies. The most effective agonists (EMAX relative to 5 nM dioxin) of the AhR were 4-Me-indole (134%), 6-Me-indole (91%), and 7-MeO-indole (80%), respectively. The most effective antagonists of the AhR included 3-Me-indole (IC50; 19 μM), 2,3-diMe-indole (IC50; 11 μM), and 2,3,7-triMe-indole (IC50; 12 μM). Reverse transcription polymerase chain reaction analyses of CYP1A1 mRNA in LS180 cells confirmed the data from gene reporter assays. The compound leads, 4-Me-indole and 7-MeO-indole, induced substantial nuclear translocation of the AhR and enriched binding of the AhR to the CYP1A1 promoter, as observed using fluorescent immunohistochemistry and chromatin immunoprecipitation assays, respectively. Molecular modeling and docking studies suggest the agonists and antagonists likely share the same binding pocket but have unique binding modes that code for their affinity. Binding pocket analysis further revealed that 4-methylindole and 7-methoxyindole can simultaneously bind to the pocket and produce synergistic interactions. Together, these data show a dependence on subtle and specific chemical indole structures as AhR modulators and furthermore underscore the importance of complete evaluation of indole compounds as nuclear receptor ligands.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19012735
003      
CZ-PrNML
005      
20190416120047.0
007      
ta
008      
190405s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1124/mol.118.112151 $2 doi
035    __
$a (PubMed)29626056
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Stepankova, Martina $u Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacky University, Olomouc, Czech Republic (M.S., I.B., E.J., R.V., Z.D.); Departments of Genetics and Medicine, Albert Einstein College of Medicine, Bronx, New York (S.M.); and Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, Pennsylvania (S.K.).
245    10
$a Methylindoles and Methoxyindoles are Agonists and Antagonists of Human Aryl Hydrocarbon Receptor / $c M. Stepankova, I. Bartonkova, E. Jiskrova, R. Vrzal, S. Mani, S. Kortagere, Z. Dvorak,
520    9_
$a Novel methylindoles were identified as endobiotic and xenobiotic ligands of the human aryl hydrocarbon receptor (AhR). We examined the effects of 22 methylated and methoxylated indoles on the transcriptional activity of AhRs. Employing reporter gene assays in AZ-AHR transgenic cells, we determined full agonist, partial agonist, or antagonist activities of tested compounds, having substantially variable EC50, IC50, and relative efficacies. The most effective agonists (EMAX relative to 5 nM dioxin) of the AhR were 4-Me-indole (134%), 6-Me-indole (91%), and 7-MeO-indole (80%), respectively. The most effective antagonists of the AhR included 3-Me-indole (IC50; 19 μM), 2,3-diMe-indole (IC50; 11 μM), and 2,3,7-triMe-indole (IC50; 12 μM). Reverse transcription polymerase chain reaction analyses of CYP1A1 mRNA in LS180 cells confirmed the data from gene reporter assays. The compound leads, 4-Me-indole and 7-MeO-indole, induced substantial nuclear translocation of the AhR and enriched binding of the AhR to the CYP1A1 promoter, as observed using fluorescent immunohistochemistry and chromatin immunoprecipitation assays, respectively. Molecular modeling and docking studies suggest the agonists and antagonists likely share the same binding pocket but have unique binding modes that code for their affinity. Binding pocket analysis further revealed that 4-methylindole and 7-methoxyindole can simultaneously bind to the pocket and produce synergistic interactions. Together, these data show a dependence on subtle and specific chemical indole structures as AhR modulators and furthermore underscore the importance of complete evaluation of indole compounds as nuclear receptor ligands.
650    _2
$a transkripční faktory bHLH $x agonisté $x antagonisté a inhibitory $7 D051792
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a cytochrom P-450 CYP1A1 $x metabolismus $7 D019363
650    _2
$a reportérové geny $x účinky léků $7 D017930
650    _2
$a buňky Hep G2 $7 D056945
650    _2
$a lidé $7 D006801
650    _2
$a indoly $x farmakologie $7 D007211
650    _2
$a ligandy $7 D008024
650    _2
$a promotorové oblasti (genetika) $x účinky léků $7 D011401
650    _2
$a messenger RNA $x metabolismus $7 D012333
650    _2
$a receptory aromatických uhlovodíků $x agonisté $x antagonisté a inhibitory $7 D018336
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a Research Support, U.S. Gov't, Non-P.H.S. $7 D013486
700    1_
$a Bartonkova, Iveta $u Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacky University, Olomouc, Czech Republic (M.S., I.B., E.J., R.V., Z.D.); Departments of Genetics and Medicine, Albert Einstein College of Medicine, Bronx, New York (S.M.); and Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, Pennsylvania (S.K.).
700    1_
$a Jiskrova, Eva $u Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacky University, Olomouc, Czech Republic (M.S., I.B., E.J., R.V., Z.D.); Departments of Genetics and Medicine, Albert Einstein College of Medicine, Bronx, New York (S.M.); and Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, Pennsylvania (S.K.).
700    1_
$a Vrzal, Radim $u Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacky University, Olomouc, Czech Republic (M.S., I.B., E.J., R.V., Z.D.); Departments of Genetics and Medicine, Albert Einstein College of Medicine, Bronx, New York (S.M.); and Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, Pennsylvania (S.K.).
700    1_
$a Mani, Sridhar $u Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacky University, Olomouc, Czech Republic (M.S., I.B., E.J., R.V., Z.D.); Departments of Genetics and Medicine, Albert Einstein College of Medicine, Bronx, New York (S.M.); and Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, Pennsylvania (S.K.) moulin@email.cz sridhar.mani@einstein.yu.edu.
700    1_
$a Kortagere, Sandhya $u Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacky University, Olomouc, Czech Republic (M.S., I.B., E.J., R.V., Z.D.); Departments of Genetics and Medicine, Albert Einstein College of Medicine, Bronx, New York (S.M.); and Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, Pennsylvania (S.K.).
700    1_
$a Dvorak, Zdenek $u Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacky University, Olomouc, Czech Republic (M.S., I.B., E.J., R.V., Z.D.); Departments of Genetics and Medicine, Albert Einstein College of Medicine, Bronx, New York (S.M.); and Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, Pennsylvania (S.K.) moulin@email.cz sridhar.mani@einstein.yu.edu.
773    0_
$w MED00003399 $t Molecular pharmacology $x 1521-0111 $g Roč. 93, č. 6 (2018), s. 631-644
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29626056 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190405 $b ABA008
991    __
$a 20190416120112 $b ABA008
999    __
$a ok $b bmc $g 1392045 $s 1051040
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 93 $c 6 $d 631-644 $e 20180406 $i 1521-0111 $m Molecular pharmacology $n Mol Pharmacol $x MED00003399
LZP    __
$a Pubmed-20190405

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...